Literature DB >> 18540358

[The indication of steroid pulse therapy and apheresis therapy for multiple sclerosis].

Satoru Ohji1, Kyoichi Nomura.   

Abstract

We discuss steroid pulse therapy and apheresis therapy indicated for the treatment of multiple sclerosis (MS). In the basic treatment course for MS, steroid pulse therapy is a first-line treatment for relapsing-remitting multiple sclerosis (RR-MS) in the course of the exacerbation, and apheresis therapy is performed in refractory cases. Treatment strategies for chronic progressive MS are not to be established. Steroid pulse therapy has been established as a treatment for MS in the active phase through randomized controlled trials (RCT). Apheresis therapy includes plasmapheresis and cytapheresis, and plasmapheresis includes plasma exchange (PE) and immunoadsorption plasmapheresis (IAPP). PE and IAPP are performed for MS treatment. PE has been established as a useful treatment for active phase MS. The efficacy of IAPP has been frequently reported, but no reports have been based on RCT. We also summarize the indications, methods, and adverse reactions of steroid pulse therapy and apheresis therapy.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18540358

Source DB:  PubMed          Journal:  Nihon Rinsho        ISSN: 0047-1852


  2 in total

1.  Preliminary analysis of month of birth in Iranian/Isfahan patients with multiple sclerosis.

Authors:  Zahra Tolou-Ghamari; Vahid Shygannejad; Fereshteh Ashtari; Ahmad Chitsaz; Abbas Ali Palizban
Journal:  Adv Biomed Res       Date:  2015-08-10

2.  Preliminary study related the incidence of methylprednisolone pulse therapy in patients visited multiple sclerosis clinic located at the isfahan kashani hospital.

Authors:  Zahra Tolou-Ghamari; Vahid Shaygannejad; Fereshteh Ashtari
Journal:  Int J Prev Med       Date:  2013-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.